Corin (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human Corin (UniProt Q9Y5Q5), expressed in HEK293 cells. Type II transmembrane serine protease that processes pro-ANP and pro-BNP into active natriuretic peptides; used in activity assays, inhibitor screens, and antibody validation.
Expression system
HEK293
Cat. #
REC-Corin

In stock

SKU
REC-Corin
$498.00

Target Overview

Corin (UniProt Q9Y5Q5; gene: CORIN) is a type II transmembrane serine endopeptidase of 1,042 amino acids, classified under EC 3.4.21.- and also known as atrial natriuretic peptide-converting enzyme, Pro-ANP-converting enzyme, heart-specific serine proteinase ATC2, and Transmembrane Protease Serine 10 (TMPRSS10). This recombinant is produced in HEK293 mammalian cells, which supports the post-translational modifications — including N-linked glycosylation across the large extracellular domain — that are characteristic of the native enzyme and important for full catalytic competence. Corin's defining biochemical function is the proteolytic maturation of pro-atrial natriuretic peptide (pro-NPPA) and pro-brain natriuretic peptide (pro-NPPB) into their respective bioactive forms, ANP and BNP(1-32). The recombinant protein is well-suited for fluorogenic or chromogenic substrate cleavage assays that quantify endopeptidase activity, for inhibitor IC50 determinations against small-molecule or peptide-based candidates, and for kinetic characterisation of substrate variants. Because glycosylation and correct disulfide bonding are preserved in HEK293-derived material, the recombinant closely approximates the enzyme's native fold, making it a reliable standard for surface plasmon resonance (SPR) binding studies and pull-down experiments designed to identify interaction partners. Researchers requiring a defined positive-control antigen for immunoassay development or antibody characterisation can pair this recombinant directly with Triple Point Biologics' matched anti-Corin antibody (catalog RP-Corin), which has been validated for Western blot applications and carries predicted cross-reactivity to non-human primate and pan-species orthologs. Species reactivity for this recombinant has been validated for human; potential cross-reactivity with monkey and pan-species targets is predicted based on sequence conservation.

Background

Corin is a cell-membrane-anchored serine protease expressed predominantly in cardiomyocytes, where it functions as the primary processing enzyme for the natriuretic peptide precursors pro-NPPA and pro-NPPB. By cleaving these propeptides into active ANP and BNP(1-32), Corin sits at a critical regulatory node governing cardiac pressure sensing, natriuresis, diuresis, and vasodilation. The enzyme's physiological importance extends beyond the myocardium: in the kidney, Corin has been studied as a regulator of sodium reabsorption, and in the uterus, pro-NPPA cleavage by Corin has been characterised as a contributor to trophoblast invasion and spiral artery remodeling during pregnancy. In cardiac research, Corin has been investigated as a target relevant to heart failure, hypertension, and related cardiorenal disorders. Studies examining fluid homeostasis in heart failure with preserved ejection fraction (HFpEF) have implicated the PCSK6/Corin axis — alongside downstream p38 MAPK signaling and aquaporin regulation — in the dysregulation of fluid balance observed in that condition (Liang X et al., J Ethnopharmacol, 2026). Separately, the natriuretic peptide pathway that Corin activates has been studied in the context of myocardial infarction recovery, where augmenting NPPA signaling represents an active area of basic research (Zhang K et al., Science, 2026). At the molecular level, published research has employed recombinant or endogenous Corin to map substrate recognition determinants within pro-ANP, to assess how disease-associated single-nucleotide variants alter enzyme activity, and to characterise small-molecule inhibitors. The serine protease catalytic triad of Corin makes it tractable for standard protease biochemistry — fluorogenic peptide substrates, active-site titration, and competitive inhibition experiments are all well-documented approaches in the literature. Because Corin is a transmembrane protein that undergoes zymogen activation at the cell surface, soluble or ectodomain-containing recombinant forms expressed in mammalian systems such as HEK293 provide a practical in-vitro tool for researchers who need enzymatic activity without a membrane bilayer. This recombinant is appropriate for biochemical characterisation, inhibitor screening, protein–protein interaction studies, and as an antigen standard in immunoassay development. Researchers working on antibody validation can pair this recombinant with Triple Point Biologics' matched anti-Corin antibody (RP-Corin), which has been in production alongside Triple Point's broader proteinase/inhibitor antibody portfolio since 1994.

Applications

  • Pro-ANP (pro-NPPA) cleavage activity assay using fluorogenic or chromogenic peptide substrates
  • Pro-BNP (pro-NPPB) processing assay to measure Corin endopeptidase kinetics (Km, kcat, Vmax)
  • Small-molecule inhibitor IC50 determination against the Corin serine protease active site
  • Positive-control antigen for Western blot validation of anti-Corin antibody (pair with RP-Corin)
  • IHC standard antigen preparation for titration and specificity confirmation of matched antibody RP-Corin
  • Surface plasmon resonance (SPR) binding studies to characterise Corin–substrate or Corin–interaction partner affinities
  • Pull-down/co-immunoprecipitation experiments to identify Corin binding partners (e.g., PCSK6 axis components)
  • Substrate specificity mapping via mass spectrometry-based cleavage site identification

References

  1. Liang X et al. LingGui QiHua-3 decoction (LGQH-3) ameliorates cardiorenal dysfunction in HFpEF by restoring fluid homeostasis via the PCSK6/Corin/p38 MAPK/AQPs axis. J Ethnopharmacol. 2026. doi:10.1016/j.jep.2026.121872. PMID: 42144208.
  2. Liang X et al. Mahuang decoction targets fluid retention in heart failure with preserved ejection fraction. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158099. PMID: 41886948.
  3. Zhang K et al. Single intramuscular injection of self-amplifying RNA of Nppa to treat myocardial infarction. Science. 2026. doi:10.1126/science.adu9394. PMID: 41785353.

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Type II transmembrane serine protease; cardiomyocyte plasma membrane

Frequently Asked Questions

What is the expected molecular weight of recombinant Corin on SDS-PAGE and Western blot?

The full-length Corin polypeptide has a predicted molecular weight of ~117 kDa based on its 1,042-amino-acid sequence. Due to extensive N-linked glycosylation across the large extracellular domain — supported by the HEK293 mammalian expression system — the apparent molecular weight on reducing SDS-PAGE typically runs between 150–200 kDa. When using our matched antibody RP-Corin for Western blot, set your marker expectations accordingly and do not mistake the upward shift for degradation or aggregation.

What processing or isoform state is this recombinant Corin — is it the full-length zymogen or the active cleaved form?

This recombinant represents the extracellular protease-competent ectodomain of Corin, produced in HEK293 cells in an active, soluble form. Native Corin undergoes autocatalytic or corin-mediated activation involving cleavage of the propeptide; the recombinant is supplied as an activated preparation suited for direct use in enzymatic assays. It retains the frizzled-type cysteine-rich domain and LDL receptor-like repeats that support proper folding and substrate recognition. Confirm activation state for your specific lot via the included activity data sheet.

What substrates can I use to measure recombinant Corin endopeptidase activity in a fluorogenic assay?

Corin's primary physiological substrates are pro-ANP (pro-NPPA) and pro-BNP (pro-NPPB), cleaved at Arg residues to release bioactive ANP and BNP(1-32). For fluorogenic assays, peptide substrates derived from the pro-ANP cleavage site — such as internally quenched FRET peptides spanning the Arg98 cleavage site of human pro-ANP — are well-established. Chromogenic substrates with a P1 Arg are also compatible. Confirm substrate Km for your lot by running a substrate saturation curve before IC50 work, as glycosylation-dependent activity can introduce lot-to-lot Km variation.

What is the recommended assay buffer for recombinant Corin activity assays and does buffer pH significantly affect activity?

Corin serine protease activity is optimal near physiological pH. A standard assay buffer of 50 mM Tris-HCl pH 7.5, 150 mM NaCl is directly compatible with the storage buffer and avoids a dilution-induced pH shift. Activity drops measurably below pH 6.5 and above pH 8.5. Adding 0.01–0.05% BSA or 0.01% Tween-20 helps minimize adsorption at low enzyme concentrations. Avoid strong reducing agents such as DTT above 1 mM, as these can disrupt the disulfide-stabilized frizzled domain and reduce specific activity.

What starting concentration of recombinant Corin should I use for IC50 inhibitor screening assays?

For IC50 determination, titrate enzyme concentration to achieve a linear signal response and consume no more than 10–15% of substrate over the assay window — a common starting point is 1–5 nM Corin with substrate at roughly 10–20 µM (below Km). Because Corin's active-site accessibility can be influenced by its glycosylated extracellular scaffold, run a preliminary dose-response of enzyme concentration (0.5–20 nM) against a fixed substrate before committing inhibitor compound. This prevents substrate depletion artifacts that compress apparent IC50 values.

Can I use recombinant Corin as a Western blot positive control with the RP-Corin rabbit polyclonal antibody?

Yes — this is one of the primary intended uses of the pairing. REC-Corin and RP-Corin are produced and validated together in the same laboratory, guaranteeing epitope compatibility. Load 50–150 ng of REC-Corin per lane on a 6–8% SDS-PAGE gel; expect a broad band at 150–200 kDa under reducing conditions owing to glycosylation. RP-Corin is validated for Western blot and provides a clean positive control signal without background bands that complicate interpretation when working with cell lysates expressing endogenous Corin.

How much recombinant Corin should I load for a Western blot positive control lane, and at what antibody dilution does RP-Corin work best?

Load 50–150 ng of REC-Corin per lane; 100 ng is a reliable starting point that gives a strong signal without overloading. Use RP-Corin at 1:500–1:2,000 in 5% non-fat milk or BSA in TBST, with an overnight 4°C primary incubation. The matched pairing means you do not need to optimize epitope retrieval conditions separately for the recombinant versus tissue samples — both are recognized by the same antibody lot used in validation. Confirm secondary antibody compatibility (anti-rabbit HRP) before running alongside endogenous Corin from cardiac tissue lysates.

How should I store and handle recombinant Corin to preserve enzymatic activity, and what is its shelf life after thawing?

REC-Corin is supplied in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol and shipped on dry ice. Store at -20°C in single-use aliquots immediately upon receipt. Once thawed, keep on ice and use within 4–6 hours; do not refreeze. Under recommended storage, activity is stable for at least 12 months from the date of manufacture. Avoid diluting to below ~0.1 µg/mL in plain buffer without a carrier protein such as 0.1% BSA, as surface adsorption at low concentrations causes measurable activity loss within hours.

Validation imagery coming soon

Western blot validation figures for REC-Corin will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →